Tempus AI, Inc. - Class A

The momentum for this stock is not very good. Tempus AI, Inc. - Class A is not a good value stock. Tempus AI, Inc. - Class A is not very popular among insiders. Tradey thinks it is not wise to invest in Tempus AI, Inc. - Class A.
Log in to see more information.

News

Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients

Business Wire Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a patient-facing app, olivia, an...\n more…

Cathie Wood's ARK Investment bought 201K shares of Tempus AI today
Cathie Wood's ARK Investment bought 201K shares of Tempus AI today

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Reviewing Tempus AI (NASDAQ:TEM) & Trade Desk (NASDAQ:TTD)
Reviewing Tempus AI (NASDAQ:TEM) & Trade Desk (NASDAQ:TTD)

Zolmax Trade Desk (NASDAQ:TTD - Get Free Report) and Tempus AI (NASDAQ:TEM - Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies...\n more…

Tempus AI (NASDAQ:TEM) vs. Trade Desk (NASDAQ:TTD) Head to Head Review
Tempus AI (NASDAQ:TEM) vs. Trade Desk (NASDAQ:TTD) Head to Head Review

Ticker Report Tempus AI (NASDAQ:TEM - Get Free Report) and Trade Desk (NASDAQ:TTD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on...\n more…

Tempus AI announces collaboration with Biontech
Tempus AI announces collaboration with Biontech

Seeking Alpha - Healthcare Tempus AI announces collaboration with Biontech...\n more…

Tempus Announces Real World Data Collaboration with BioNTech
Tempus Announces Real World Data Collaboration with BioNTech

Business Wire Tempus AI, Inc. (NASDAQ: TEM, Tempus), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a multi-year collaboration with BioNTech SE...\n more…